Youngy Health Income Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Operating Revenue	913.47	925.21	681.18	521.77	453.79	516.31
Other Revenue	7.94	7.94	7.61	7.68	9.53	10.19
Revenue	921.41	933.15	688.79	529.45	463.32	526.5
Revenue Growth (YoY)	20.59%	35.48%	30.10%	14.27%	-12.00%	2.42%
Cost of Revenue	589.26	600.83	472.78	363.03	354.61	408.31
Gross Profit	332.16	332.32	216.01	166.42	108.71	118.19
Selling, General & Admin	177.87	176.07	135.12	119.56	105.05	97.46
Research & Development	12.37	12.27	11.7	9.06	10.97	13.52
Other Operating Expenses	7.93	6.32	4.82	4.8	4.6	3.94
Operating Expenses	197.28	195.32	153.2	133.48	121.52	105.9
Operating Income	134.88	137	62.81	32.94	-12.81	12.29
Interest Expense	-1.07	-	-	-	-0	-
Interest & Investment Income	11.31	14.44	16.53	11.88	136	9.74
Currency Exchange Gain (Loss)	-5.5	-5.5	3.06	2.34	9.05	-3.45
Other Non Operating Income (Expenses)	-3.47	-2.51	-0.98	-1.8	-0.18	1.09
EBT Excluding Unusual Items	136.15	143.43	81.42	45.36	132.05	19.66
Gain (Loss) on Sale of Investments	0.67	0.51	5.66	13.32	3.38	15.86
Gain (Loss) on Sale of Assets	-0.08	-0.09	0.01	-0.5	0.59	0.03
Asset Writedown	-0.07	-0.07	-0.95	-0.38	-0.31	0.03
Other Unusual Items	4.45	4.15	2.01	1.96	0.68	2.19
Pretax Income	141.12	147.93	88.15	59.76	136.39	37.77
Income Tax Expense	39.59	39.79	22.1	17.84	3.06	6.32
Earnings From Continuing Operations	101.53	108.15	66.06	41.92	133.33	31.45
Minority Interest in Earnings	-33.98	-33.34	-19.2	-15.34	-7.02	-7.25
Net Income	67.55	74.8	46.85	26.58	126.31	24.2
Net Income to Common	67.55	74.8	46.85	26.58	126.31	24.2
Net Income Growth	18.49%	59.65%	76.26%	-78.95%	421.87%	-
Shares Outstanding (Basic)	831	831	781	886	789	807
Shares Outstanding (Diluted)	831	831	781	886	789	807
Shares Change (YoY)	6.40%	6.43%	-11.87%	12.24%	-2.15%	-1.81%
EPS (Basic)	0.08	0.09	0.06	0.03	0.16	0.03
EPS (Diluted)	0.08	0.09	0.06	0.03	0.16	0.03
EPS Growth	11.36%	50.00%	100.00%	-81.25%	433.33%	-
Free Cash Flow	67.26	105.84	42.2	80.53	-46.72	4.6
Free Cash Flow Per Share	0.08	0.13	0.05	0.09	-0.06	0.01
Gross Margin	36.05%	35.61%	31.36%	31.43%	23.46%	22.45%
Operating Margin	14.64%	14.68%	9.12%	6.22%	-2.77%	2.33%
Profit Margin	7.33%	8.02%	6.80%	5.02%	27.26%	4.60%
Free Cash Flow Margin	7.30%	11.34%	6.13%	15.21%	-10.08%	0.87%
EBITDA	150.77	152.97	79.09	50.16	5.45	29.49
EBITDA Margin	16.36%	16.39%	11.48%	9.47%	1.18%	5.60%
D&A For EBITDA	15.9	15.98	16.28	17.22	18.27	17.2
EBIT	134.88	137	62.81	32.94	-12.81	12.29
EBIT Margin	14.64%	14.68%	9.12%	6.22%	-2.77%	2.33%
Effective Tax Rate	28.05%	26.90%	25.07%	29.85%	2.25%	16.73%
Revenue as Reported	921.41	933.15	688.79	529.45	463.32	526.5
Advertising Expenses	-	9.7	11.26	8.01	7.84	6.1

Source: S&P Global Market Intelligence. Standard template. Financial Sources.